Dual certifications streamline global design transfers and regulatory compliance.

TAIPEI, Nov. 21, 2025 /PRNewswire/ -- IEI Integration Corp. ("IEI"), a global provider of medical and industrial computing platforms, today announced that its New Taipei City (Xizhi) and Qidu (Keelung) facilities have passed inspection by the Taiwan Food and Drug Administration (TFDA) and been awarded Quality Management System (QMS) approval (Xizhi Certificate No. QMS2376、Keelung Certificate No. QMS2377), while maintaining ISO 13485:2016 certification. As one of Taiwan's manufacturers holding both domestic and international medical QMS credentials, IEI enables OEM/ODM/CDMO clients to accelerate regulatory readiness and scale production across Asia, the United States, and Europe.

Backed by TFDA Class II credentials, IEI is prioritizing CDMO partnerships in medical imaging peripherals, vital-sign monitoring, and endoscopy/OR integration—bringing compliant designs to clinical use faster.

IEI's Qidu (Chi-Du) campus delivers 38K PCBA units per month and 38K system units per month, supporting rapid ramps and regional fulfillment. Additional capacity in Taoyuan is under planning, with a phased build-out to support forecast demand and regionalized logistics

"Layering TFDA approval on top of ISO 13485 enables smoother, more predictable audits, faster design transfers, and more reliable scale-up in regulated markets." said Kenny Jan, Senior Vice President of IEI's Medical Business Unit.

For a Europe-based Class II endoscopic device program, IEI applied a highly automated smart-factory toolset—pick-to-light material handling, X-ray component counting, and automatic visual identification—to stabilize ramp. MES-linked traceability, AXI/vision inspection, and documented CAPA evidence further supported audit readiness.

Operating under its unified governance model—the IEI "Trust Stack"—IEI runs an ISO 13485/TFDA-compliant smart factory that spans ISO/IEC 27001 (information security), ISO 28000 (supply-chain security), IECQ QC 080000 (hazardous-substance process governance), and organization-level ISO 14064-1 GHG accounting. This framework reduces validation time, simplifies audits, and ensures end-to-end transparency for MedTech brands.

By aligning domestic TFDA compliance with global ISO frameworks, IEI provides medical customers with a transparent, audit-ready manufacturing base built for multi-market expansion.

About IEI Integration Corp.

Founded in 1997, IEI Integration Corp. is a global provider of medical and industrial computing platforms and CDMO/ODM services. IEI enables regulated MedTech and edge-AI applications through design-to-manufacturing expertise, delivering advanced medical computers, network appliances, and embedded platforms supported by robust quality, regulatory, and cybersecurity frameworks.

For more MedTech information, visit the IEI Medical Portal.
Learn more about IEI at www.ieiworld.com/en.

IEI Integration Corp. announces its TFDA Quality Management System (QMS) approval and continued ISO 13485:2016 certification, reinforcing audit-ready manufacturing capabilities for medical device design transfers and regulated production.

PR Newswire Asia Ltd.

PR Newswire
1954年に設立された世界初の米国広報通信社です。配信ネットワークで全世界をカバーしています。Cision Ltd.の子会社として、Cisionクラウドベースコミュニケーション製品、世界最大のマルチチャネル、多文化コンテンツ普及ネットワークと包括的なワークフローツールおよびプラットフォームを組み合わせることで、様々な組織のストーリーを支えています。www.prnasia.com